{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:50:11Z","timestamp":1775746211189,"version":"3.50.1"},"reference-count":83,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271096"],"award-info":[{"award-number":["82271096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Retinal vascular occlusion (RVO) and retinal artery occlusion (RAO) have been reported as rare adverse events following COVID-19 vaccination, raising concerns about vaccine safety. This review synthesizes cohort and case\u2013control studies assessing the association between COVID-19 vaccines and RVO\/RAO, while exploring potential pathophysiological mechanisms. Methods: We analyzed large-scale population-based studies from South Korea, Europe, and the TriNetX database, focusing on odds ratios (OR), hazard ratios (HR), and relative risks (RR) across mRNA and adenoviral vector vaccines. Pathological processes were hypothesized based on molecular and clinical evidence. Results: Studies investigating the association between COVID-19 vaccination and retinal vascular occlusion show conflicting results; some studies report no association (e.g., OR 0.93, 95% CI 0.60\u20131.45), others suggest reduced risk (e.g., OR 0.80, 95% CI 0.64\u20130.99), and one indicates increased risk over two years (HR 2.19, 95% CI 2.00\u20132.39). Adenoviral vector vaccines, particularly ChAdOx1, show higher RAO incidence in specific cohorts. Proposed mechanisms include vaccine-induced immune thrombotic thrombocytopenia (VITT) via anti-PF4 antibodies, spike protein-mediated endothelial dysfunction, and adjuvant-driven inflammation. Conclusions: While causality remains unproven, temporal heterogeneity and vaccine type-specific risks warrant further investigation. Longitudinal studies with robust controls are needed to clarify these associations in the post-pandemic context.<\/jats:p>","DOI":"10.3390\/vaccines13070733","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:03:27Z","timestamp":1751882607000},"page":"733","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retinal Vascular Occlusion Following COVID-19 Vaccination: A Comprehensive Review of Observational Study and Pathophysiological Mechanisms"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5401-1926","authenticated-orcid":false,"given":"Yuchen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"National Clinical Research Center for Ophthalmic Diseases, Shanghai 200080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8154-1192","authenticated-orcid":false,"given":"Haoliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"National Clinical Research Center for Ophthalmic Diseases, Shanghai 200080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangjia","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"National Clinical Research Center for Ophthalmic Diseases, Shanghai 200080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3390-7528","authenticated-orcid":false,"given":"Xin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350000, China"},{"name":"Department of Ophthalmology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou 350000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng\u2019e","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"National Clinical Research Center for Ophthalmic Diseases, Shanghai 200080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"National Clinical Research Center for Ophthalmic Diseases, Shanghai 200080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8625-5367","authenticated-orcid":false,"given":"Chong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"},{"name":"Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"n436","DOI":"10.1136\/bmj.n436","article-title":"Severe covid-19 pneumonia: Pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41579-021-00535-6","article-title":"Transmissibility and transmission of respiratory viruses","volume":"19","author":"Leung","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/JOCO.JOCO_255_20","article-title":"An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards","volume":"32","author":"Badawi","year":"2020","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101285","DOI":"10.1016\/j.preteyeres.2024.101285","article-title":"Ocular manifestations of COVID-19","volume":"102","author":"Ng","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaophthalmol.2022.0632","article-title":"Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis","volume":"140","author":"Modjtahedi","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00417-022-05953-7","article-title":"Retinal vascular occlusions in COVID-19 infection and vaccination: A literature review","volume":"261","author":"Yeo","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/IAE.0000000000003952","article-title":"RETINAL VASCULAR OCCLUSION AND COVID-19 DIAGNOSIS: A Multicenter Population-Based Study","volume":"44","author":"Li","year":"2024","journal-title":"Retina"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Park, H.S., Kim, S., Lee, C.S., Byeon, S.H., Kim, S.S., Lee, S.W., and Kim, Y.J. (2023). Retinal vascular occlusion risks during the COVID-19 pandemic and after SARS-CoV-2 infection. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-44199-z"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00151-8","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","first-page":"n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population based cohort study","volume":"373","author":"Lund","year":"2021","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"ref_12","first-page":"n1931","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: Self-controlled case series study","volume":"374","author":"Patone","year":"2021","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"n699","DOI":"10.1136\/bmj.n699","article-title":"Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots","volume":"372","author":"Wise","year":"2021","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"010427","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: A systematic review and meta\u2014Analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.13.4.28","article-title":"Trends in the Prevalence of Common Retinal and Optic Nerve Diseases in China: An Artificial Intelligence Based National Screening","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/APO.0000000000000598","article-title":"Update on Retinal Vein Occlusion","volume":"12","author":"Romano","year":"2023","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14779072.2022.2112667","article-title":"A review of risk factors for retinal vein occlusions","volume":"20","author":"Vorum","year":"2022","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: Pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ophtha.2014.04.029","article-title":"Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011","volume":"121","author":"Park","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/09286586.2024.2399345","article-title":"Retinal Vascular Occlusions After COVID-19 Vaccination in South Korea: A Nation-Wide Population-Based Study","volume":"32","author":"Kim","year":"2025","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajo.2024.08.015","article-title":"COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population","volume":"269","author":"Hwang","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2023.09.019","article-title":"Retinal Artery and Vein Occlusion Risks after Coronavirus Disease 2019 or Coronavirus Disease 2019 Vaccination","volume":"131","author":"Park","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41541-023-00661-7","article-title":"Risk assessment of retinal vascular occlusion after COVID-19 vaccination","volume":"8","author":"Li","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaophthalmol.2023.0610","article-title":"Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data","volume":"141","author":"Dorney","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/s41433-023-02459-2","article-title":"Risk of retinal vein occlusion following COVID-19 vaccination: A self-controlled case series","volume":"37","author":"Pellegrini","year":"2023","journal-title":"Eye"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Feltgen, N., Ach, T., Ziemssen, F., Quante, C.S., Gross, O., Abdin, A.D., Aisenbrey, S., Bartram, M.C., Blum, M., and Brockmann, C. (2022). Retinal Vascular Occlusion after COVID-19 Vaccination: More Coincidence than Causal Relationship? Data from a Retrospective Multicentre Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175101"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ophtha.2022.10.017","article-title":"Ocular Adverse Events after Coronavirus Disease 2019 mRNA Vaccination: Matched Cohort and Self-Controlled Case Series Studies Using a Large Database","volume":"130","author":"Hashimoto","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Uzun, G., Ringelmann, T., Hammer, S., Zlamal, J., Luz, B., Wolf, M.E., Henkes, H., Bakchoul, T., and Althaus, K. (2024). Subsequent Vaccination against SARS-CoV-2 after Vaccine-Induced Immune Thrombotic Thrombocytopenia. J. Clin. Med., 13.","DOI":"10.3390\/jcm13185462"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V58.3.607.607","article-title":"Studies of human platelet \u03b1\u2014Granule release in vivo","volume":"58","author":"Files","year":"1981","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/bj3120357","article-title":"Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: Arginine residues are crucial for binding","volume":"312","author":"Mayo","year":"1995","journal-title":"Biochem. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101155","DOI":"10.1016\/j.blre.2023.101155","article-title":"Platelet factor 4(PF4) and its multiple roles in diseases","volume":"64","author":"Liu","year":"2024","journal-title":"Blood Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2022.02.004","article-title":"Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"59","author":"Greinacher","year":"2022","journal-title":"Semin. Hematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eabl8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood.2021014712","article-title":"Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration","volume":"140","author":"Nicolai","year":"2022","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12038-012-9192-8","article-title":"Nucleic acids in circulation: Are they harmful to the host?","volume":"37","author":"Mittra","year":"2012","journal-title":"J. Biosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e74974","DOI":"10.7554\/eLife.74974","article-title":"Vaccine-induced COVID-19 mimicry syndrome","volume":"11","author":"Kowarz","year":"2022","journal-title":"eLife"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS\u2014CoV\u20142 receptor: Molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/eji.202149470","article-title":"Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients","volume":"52","author":"Hagemann","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e29527","DOI":"10.1002\/jmv.29527","article-title":"SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines","volume":"96","author":"Zedan","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lamerton, R.E., Marcial-Juarez, E., Faustini, S.E., Perez-Toledo, M., Goodall, M., Jossi, S.E., Newby, M.L., Chapple, I., Dietrich, T., and Veenith, T. (2022). SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.838780"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41440-022-00876-6","article-title":"The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness","volume":"45","author":"Gardikioti","year":"2022","journal-title":"Hypertens. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2317026121","DOI":"10.1073\/pnas.2317026121","article-title":"Human transferrin receptor can mediate SARS-CoV-2 infection","volume":"121","author":"Liao","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","unstructured":"Veronese, F.M. (2009). The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol). PEGylated Protein Drugs: Basic Science and Clinical Applications, Birkh\u00e4user Verlag."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000233512","article-title":"Polyethylene glycol reactive antibodies in man: Titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Reinke, S., Thakur, A., Gartlan, C., Bezbradica, J.S., and Milicic, A. (2020). Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants. Vaccines, 8.","DOI":"10.3390\/vaccines8030554"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: Modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"15203","DOI":"10.1021\/acsami.3c00502","article-title":"Amifostine-Loaded Nanocarrier Traverses the Blood-Brain Barrier and Prevents Radiation-Induced Brain Injury","volume":"15","author":"Zhao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/all.15571","article-title":"Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis","volume":"78","author":"Greenhawt","year":"2023","journal-title":"Allergy"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Azzarone, B., Veneziani, I., Moretta, L., and Maggi, E. (2021). Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.728513"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, Z., Guo, J., and Bi, L. (2020). Role of the NLRP3 inflammasome in autoimmune diseases. Biomed. Pharmacother., 130.","DOI":"10.1016\/j.biopha.2020.110542"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/all.14711","article-title":"Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?","volume":"76","author":"Cabanillas","year":"2021","journal-title":"Allergy"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bakos, T., M\u00e9sz\u00e1ros, T., Kozma, G.T., Ber\u00e9nyi, P., Facsk\u00f3, R., Farkas, H., D\u00e9zsi, L., Heirman, C., de Koker, S., and Schiffelers, R. (2024). mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions. Int. J. Mol. Sci., 25.","DOI":"10.1101\/2024.01.12.575122"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Leung, H.M., and Au, S.C. (2023). Retinal Vein Occlusion after COVID-19 Vaccination\u2014A Review. Vaccines, 11.","DOI":"10.3390\/vaccines11081281"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/all.14722","article-title":"COVID-19 vaccine anaphylaxis: PEG or not?","volume":"76","author":"Krantz","year":"2021","journal-title":"Allergy"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/all.14774","article-title":"Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines","volume":"76","author":"Borgsteede","year":"2021","journal-title":"Allergy"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/BOR.0b013e32835ad3ca","article-title":"Thrombosis in vasculitis","volume":"25","author":"Springer","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.34172\/bi.2023.27494","article-title":"SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and\/or bystander activation of the immune system","volume":"13","author":"Safary","year":"2023","journal-title":"BioImpacts BI"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Talotta, R. (2023). Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis. Microorganisms, 11.","DOI":"10.3390\/microorganisms11071686"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jleuko\/qiac016","article-title":"Ocular immune privilege and retinal pigment epithelial cells","volume":"113","author":"Du","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"104500","DOI":"10.1016\/j.mvr.2023.104500","article-title":"Evaluation of retinal and optic disc vascular structures in individuals before and after Pfizer-BioNTech vaccination","volume":"147","author":"Gedik","year":"2023","journal-title":"Microvasc. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"102742","DOI":"10.1016\/j.pdpdt.2022.102742","article-title":"The assesment of retina and optic disc vascular structures in people who received CoronaVac vaccine","volume":"38","author":"Gedik","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"103702","DOI":"10.1016\/j.pdpdt.2023.103702","article-title":"Effects of Sinovac-Coronavac and Pfizer-BioNTech mRNA vaccines on choroidal and retinal vascular system","volume":"43","author":"Yorgun","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMc2402592","article-title":"Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders","volume":"390","author":"Wang","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s15010-024-02439-y","article-title":"Syncopes, paresis and loss of vision after COVID-19 mRNA-based vaccination and SARS-CoV-2 infection","volume":"53","author":"Weirauch","year":"2025","journal-title":"Infection"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kamoi, K., and Ohno-Matsui, K. (2024). Long Vax in the Eye: Long Post-COVID Vaccination Syndrome Presenting with Frosted Branch Angiitis. Diseases, 12.","DOI":"10.3390\/diseases12020036"},{"key":"ref_78","first-page":"e32433","article-title":"A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose","volume":"14","author":"Finsterer","year":"2022","journal-title":"Cureus"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa2415930","article-title":"VITT-like Monoclonal Gammopathy of Thrombotic Significance","volume":"392","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Warkentin, T.E. (Int. J. Lab. Hematol, 2025). Classification of Platelet-Activating Anti-Platelet Factor 4 Disorders, Int. J. Lab. Hematol, early view.","DOI":"10.1111\/ijlh.14486"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cell.2022.01.009","article-title":"An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity","volume":"185","author":"Borriello","year":"2022","journal-title":"Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"111062","DOI":"10.1016\/j.intimp.2023.111062","article-title":"Graphene oxide as novel vaccine adjuvant","volume":"125","author":"Vakili","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"156268","DOI":"10.1016\/j.cyto.2023.156268","article-title":"Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts","volume":"169","author":"Rahman","year":"2023","journal-title":"Cytokine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/7\/733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:05:35Z","timestamp":1760033135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/7\/733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":83,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["vaccines13070733"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13070733","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}